{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:45:04Z","timestamp":1790631904396,"version":"4.1.0"},"reference-count":120,"publisher":"Society of Nuclear Medicine","issue":"Supplement 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.2967\/jnumed.110.085753","type":"journal-article","created":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T20:05:49Z","timestamp":1323115549000},"page":"42S-55S","source":"Crossref","is-referenced-by-count":176,"title":["Radiopeptide Imaging and Therapy in Europe"],"prefix":"10.2967","volume":"52","author":[{"given":"Valentina","family":"Ambrosini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melpomeni","family":"Fani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Forrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut R.","family":"Maecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2011,12,5]]},"reference":[{"key":"2021051712024087000_52.Supplement_2.42S.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2006.12.003"},{"key":"2021051712024087000_52.Supplement_2.42S.2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.053314"},{"key":"2021051712024087000_52.Supplement_2.42S.3","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-59-6-1148"},{"key":"2021051712024087000_52.Supplement_2.42S.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91258-0"},{"key":"2021051712024087000_52.Supplement_2.42S.5","doi-asserted-by":"publisher","DOI":"10.1007\/BF00181765"},{"key":"2021051712024087000_52.Supplement_2.42S.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.7431"},{"key":"2021051712024087000_52.Supplement_2.42S.7","doi-asserted-by":"publisher","DOI":"10.2217\/14796694.5.1.75"},{"key":"2021051712024087000_52.Supplement_2.42S.8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF00171420","article-title":"Synthesis, radiochemistry and biological evaluation of a new somatostatin analogue (SDZ 219-387) labelled with technetium-99m","volume":"21","author":"Maina","year":"1994","journal-title":"Eur J Nucl Med."},{"key":"2021051712024087000_52.Supplement_2.42S.9","first-page":"791P","article-title":"New somatostatin analogues labelled with technetium-99m [abstract]","volume":"22(suppl)","author":"B\u00e9h\u00e9","year":"1995","journal-title":"Eur J Nucl Med."},{"key":"2021051712024087000_52.Supplement_2.42S.10","doi-asserted-by":"publisher","DOI":"10.1007\/s002590000289"},{"key":"2021051712024087000_52.Supplement_2.42S.11","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050556"},{"key":"2021051712024087000_52.Supplement_2.42S.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-003-1225-y"},{"key":"2021051712024087000_52.Supplement_2.42S.13","first-page":"889","article-title":"Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy","volume":"43","author":"Lebtahi","year":"2002","journal-title":"J Nucl Med."},{"key":"2021051712024087000_52.Supplement_2.42S.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0113-7"},{"key":"2021051712024087000_52.Supplement_2.42S.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-007-0476-4"},{"key":"2021051712024087000_52.Supplement_2.42S.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.046961"},{"key":"2021051712024087000_52.Supplement_2.42S.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0317-x"},{"key":"2021051712024087000_52.Supplement_2.42S.18","doi-asserted-by":"publisher","DOI":"10.1007\/s002590100639"},{"key":"2021051712024087000_52.Supplement_2.42S.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1536-1632(03)00038-6"},{"key":"2021051712024087000_52.Supplement_2.42S.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.106.035667"},{"key":"2021051712024087000_52.Supplement_2.42S.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.060236"},{"key":"2021051712024087000_52.Supplement_2.42S.22","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050034"},{"key":"2021051712024087000_52.Supplement_2.42S.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.066134"},{"key":"2021051712024087000_52.Supplement_2.42S.24","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-007-0587-y"},{"key":"2021051712024087000_52.Supplement_2.42S.25","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0769-2"},{"key":"2021051712024087000_52.Supplement_2.42S.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2008.01.010"},{"key":"2021051712024087000_52.Supplement_2.42S.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1205-y"},{"key":"2021051712024087000_52.Supplement_2.42S.28","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.071712"},{"key":"2021051712024087000_52.Supplement_2.42S.29","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.066662"},{"issue":"suppl 2","key":"2021051712024087000_52.Supplement_2.42S.30","first-page":"S201","article-title":"Comparison of 68Ga-DOTA-NOC and 68Ga-DOTA-TATE PET\/CT in the detection of GEP NETs [abstract]","volume":"36","author":"Wild","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2021051712024087000_52.Supplement_2.42S.31","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-1030-8"},{"key":"2021051712024087000_52.Supplement_2.42S.32","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0350-9"},{"key":"2021051712024087000_52.Supplement_2.42S.33","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23469"},{"key":"2021051712024087000_52.Supplement_2.42S.34","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0110-x"},{"key":"2021051712024087000_52.Supplement_2.42S.35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0607761103"},{"key":"2021051712024087000_52.Supplement_2.42S.36","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.087999"},{"key":"2021051712024087000_52.Supplement_2.42S.37","first-page":"1519","article-title":"Systemic radionuclide therapy using indium-111-DTPA-D-Phe1-octreotide in midgut carcinoid syndrome","volume":"37","author":"Fj\u00e4lling","year":"1996","journal-title":"J Nucl Med."},{"key":"2021051712024087000_52.Supplement_2.42S.38","first-page":"1704","article-title":"Peptide receptor imaging and therapy","volume":"41","author":"Kwekkeboom","year":"2000","journal-title":"J Nucl Med."},{"key":"2021051712024087000_52.Supplement_2.42S.39","doi-asserted-by":"publisher","DOI":"10.1053\/snuc\/2002.31025"},{"key":"2021051712024087000_52.Supplement_2.42S.40","doi-asserted-by":"publisher","DOI":"10.1053\/snuc.2002.31027"},{"key":"2021051712024087000_52.Supplement_2.42S.41","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2006.03.007"},{"key":"2021051712024087000_52.Supplement_2.42S.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2009.03.012"},{"key":"2021051712024087000_52.Supplement_2.42S.43","first-page":"792","article-title":"DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy","volume":"24","author":"Otte","year":"1997","journal-title":"Eur J Nucl Med."},{"key":"2021051712024087000_52.Supplement_2.42S.44","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)78355-0"},{"key":"2021051712024087000_52.Supplement_2.42S.45","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011160913619"},{"key":"2021051712024087000_52.Supplement_2.42S.46","first-page":"610","article-title":"Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq 90Y-DOTATOC","volume":"43","author":"Waldherr","year":"2002","journal-title":"J Nucl Med."},{"key":"2021051712024087000_52.Supplement_2.42S.47","first-page":"703","article-title":"Targeted radionuclide therapy with 90Y-DOTATOC in patients with neuroendocrine tumors","volume":"26","author":"Forrer","year":"2006","journal-title":"Anticancer Res."},{"key":"2021051712024087000_52.Supplement_2.42S.48","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-002-1023-y"},{"key":"2021051712024087000_52.Supplement_2.42S.49","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s00259-004-1571-4","article-title":"Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours","volume":"31","author":"Bodei","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712024087000_52.Supplement_2.42S.50","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2006.01.001"},{"key":"2021051712024087000_52.Supplement_2.42S.51","doi-asserted-by":"publisher","DOI":"10.1159\/000051858"},{"key":"2021051712024087000_52.Supplement_2.42S.52","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.7873"},{"key":"2021051712024087000_52.Supplement_2.42S.53","doi-asserted-by":"publisher","DOI":"10.1053\/snuc.2002.31565"},{"key":"2021051712024087000_52.Supplement_2.42S.54","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-31203-1_18"},{"key":"2021051712024087000_52.Supplement_2.42S.55","doi-asserted-by":"publisher","DOI":"10.1007\/s00761-004-0771-7"},{"key":"2021051712024087000_52.Supplement_2.42S.56","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp372"},{"key":"2021051712024087000_52.Supplement_2.42S.57","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-002-1050-8"},{"key":"2021051712024087000_52.Supplement_2.42S.58","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.2553"},{"key":"2021051712024087000_52.Supplement_2.42S.59","first-page":"1310","article-title":"Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOC","volume":"46","author":"Forrer","year":"2005","journal-title":"J Nucl Med."},{"key":"2021051712024087000_52.Supplement_2.42S.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2006.07.030"},{"key":"2021051712024087000_52.Supplement_2.42S.61","first-page":"84","article-title":"Treatment with tandem [90Y]DOTA-TATE an [177Lu] DOTA-TATE of neuroendocrine tumors refractory to conventional therapy: preliminary results","volume":"54","author":"Seregni","year":"2010","journal-title":"Q J Nucl Med Mol Imaging."},{"key":"2021051712024087000_52.Supplement_2.42S.62","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-011-1833-x"},{"key":"2021051712024087000_52.Supplement_2.42S.63","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.106.038679"},{"key":"2021051712024087000_52.Supplement_2.42S.64","doi-asserted-by":"publisher","DOI":"10.1097\/01.RVI.0000140638.55375.1E"},{"key":"2021051712024087000_52.Supplement_2.42S.65","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2031"},{"key":"2021051712024087000_52.Supplement_2.42S.66","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.085142"},{"key":"2021051712024087000_52.Supplement_2.42S.67","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0802045"},{"key":"2021051712024087000_52.Supplement_2.42S.68","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1082"},{"key":"2021051712024087000_52.Supplement_2.42S.69","doi-asserted-by":"publisher","DOI":"10.1002\/med.2610150502"},{"key":"2021051712024087000_52.Supplement_2.42S.70","doi-asserted-by":"publisher","DOI":"10.1124\/mol.58.3.601"},{"key":"2021051712024087000_52.Supplement_2.42S.71","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65525-3"},{"key":"2021051712024087000_52.Supplement_2.42S.72","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-004-1476-2"},{"key":"2021051712024087000_52.Supplement_2.42S.73","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0045(20000301)42:4<295::AID-PROS7>3.0.CO;2-B"},{"key":"2021051712024087000_52.Supplement_2.42S.74","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-0115(00)00114-2"},{"issue":"suppl 1","key":"2021051712024087000_52.Supplement_2.42S.75","first-page":"67S","article-title":"Candidates for peptide receptor radiotherapy today and in the future","volume":"46","author":"Reubi","year":"2005","journal-title":"J Nucl Med."},{"key":"2021051712024087000_52.Supplement_2.42S.76","doi-asserted-by":"publisher","DOI":"10.1007\/s002590000355"},{"key":"2021051712024087000_52.Supplement_2.42S.77","first-page":"1722","article-title":"Biodistribution and dosimetry of 99mTc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies","volume":"42","author":"Van de Wiele","year":"2001","journal-title":"J Nucl Med."},{"key":"2021051712024087000_52.Supplement_2.42S.78","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.047167"},{"key":"2021051712024087000_52.Supplement_2.42S.79","doi-asserted-by":"publisher","DOI":"10.1021\/bc0603788"},{"key":"2021051712024087000_52.Supplement_2.42S.80","doi-asserted-by":"publisher","DOI":"10.1021\/bc034018l"},{"key":"2021051712024087000_52.Supplement_2.42S.81","doi-asserted-by":"publisher","DOI":"10.1089\/108497804773391649"},{"key":"2021051712024087000_52.Supplement_2.42S.82","doi-asserted-by":"publisher","DOI":"10.1021\/jm030383m"},{"key":"2021051712024087000_52.Supplement_2.42S.83","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.039487"},{"key":"2021051712024087000_52.Supplement_2.42S.84","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1596-9"},{"key":"2021051712024087000_52.Supplement_2.42S.85","doi-asserted-by":"publisher","DOI":"10.1021\/bc9000245"},{"key":"2021051712024087000_52.Supplement_2.42S.86","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.082826"},{"key":"2021051712024087000_52.Supplement_2.42S.87","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3845"},{"key":"2021051712024087000_52.Supplement_2.42S.88","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.106.038091"},{"key":"2021051712024087000_52.Supplement_2.42S.89","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e318203bb24"},{"issue":"suppl 1","key":"2021051712024087000_52.Supplement_2.42S.90","first-page":"7P","article-title":"Evaluation of the GRPR radioantagonist 64Cu-CB-TE2A-AR-06 in mice and men [abstract]","volume":"52","author":"Gornik","year":"2011","journal-title":"J Nucl Med."},{"issue":"suppl 2","key":"2021051712024087000_52.Supplement_2.42S.91","first-page":"S221","article-title":"177Lu-AMBA bombesin analogue in hormone refractory prostate cancer patients: a phase I escalation study with single-cycle administrations [abstract]","volume":"34","author":"Bodei","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712024087000_52.Supplement_2.42S.92","first-page":"1377","article-title":"Cholecystokinin(CCK)-A and CCK-B\/gastrin receptors in human tumors","volume":"57","author":"Reubi","year":"1997","journal-title":"Cancer Res."},{"key":"2021051712024087000_52.Supplement_2.42S.93","first-page":"1029","article-title":"Radiolabeled peptides for targeting cholecystokinin-B\/gastrin receptor-expressing tumors","volume":"40","author":"Behr","year":"1999","journal-title":"J Nucl Med."},{"key":"2021051712024087000_52.Supplement_2.42S.94","doi-asserted-by":"publisher","DOI":"10.1677\/erc.1.01245"},{"key":"2021051712024087000_52.Supplement_2.42S.95","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0157-8"},{"key":"2021051712024087000_52.Supplement_2.42S.96","doi-asserted-by":"publisher","DOI":"10.1053\/snuc.2002.31028"},{"key":"2021051712024087000_52.Supplement_2.42S.97","doi-asserted-by":"publisher","DOI":"10.1021\/jm101279a"},{"key":"2021051712024087000_52.Supplement_2.42S.98","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-011-1818-9"},{"key":"2021051712024087000_52.Supplement_2.42S.99","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-011-1806-0"},{"key":"2021051712024087000_52.Supplement_2.42S.100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020070"},{"key":"2021051712024087000_52.Supplement_2.42S.101","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0266"},{"key":"2021051712024087000_52.Supplement_2.42S.102","first-page":"1333","article-title":"Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients","volume":"46","author":"Beer","year":"2005","journal-title":"J Nucl Med."},{"key":"2021051712024087000_52.Supplement_2.42S.103","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.045864"},{"key":"2021051712024087000_52.Supplement_2.42S.104","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0528"},{"key":"2021051712024087000_52.Supplement_2.42S.105","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.045526"},{"key":"2021051712024087000_52.Supplement_2.42S.106","doi-asserted-by":"publisher","DOI":"10.1215\/15228517-2009-024"},{"key":"2021051712024087000_52.Supplement_2.42S.107","first-page":"1434","article-title":"Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99mTc-NC100692","volume":"47","author":"Bach-Gansmo","year":"2006","journal-title":"J Nucl Med."},{"key":"2021051712024087000_52.Supplement_2.42S.108","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.049452"},{"key":"2021051712024087000_52.Supplement_2.42S.109","unstructured":"A proof-of-concept study to assess the ability of [18F]AH-111585 PET imaging to detect tumours and angiogenesis. ClinicalTrials.gov Web site. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00565721?term=A+proof-of-concept+study+to+assess+the+ability+AH-111585+PET+imaging+to+detect+tumours+and+angiogenesis&rank=1. Accessed November 9, 2011."},{"key":"2021051712024087000_52.Supplement_2.42S.110","unstructured":"Cho HJ Lee JD Park JY . First in human evaluation of a newly developed PET tracer, 18FRGD-K5 in patients with breast cancer: comparison with 18FFDG uptake pattern and microvessel density [abstract]. J Nucl Med. 50(suppl 2):403P."},{"key":"2021051712024087000_52.Supplement_2.42S.111","unstructured":"Efficacy study of [18F]RGD-K5 positron emission tomography (PET) as a tool to monitor response to an antiangiogenic drug (K5-101). ClinicalTrials.gov Web site. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00988936?term=Efficacy+study+of+RGD-K5+positron+emission+tomography+%28PET%29+as+a+tool+to+monitor+response+to+an+antiangiogenic+drug+%28K5-101%29&rank=1. Accessed November 9, 2011."},{"key":"2021051712024087000_52.Supplement_2.42S.112","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1503-4"},{"key":"2021051712024087000_52.Supplement_2.42S.113","first-page":"1025","article-title":"Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas","volume":"5","author":"Merlo","year":"1999","journal-title":"Clin Cancer Res."},{"key":"2021051712024087000_52.Supplement_2.42S.114","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-001-0717-x"},{"key":"2021051712024087000_52.Supplement_2.42S.115","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910610608"},{"key":"2021051712024087000_52.Supplement_2.42S.116","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2820"},{"key":"2021051712024087000_52.Supplement_2.42S.117","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0351-8"},{"key":"2021051712024087000_52.Supplement_2.42S.118","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-010-0153-5"},{"key":"2021051712024087000_52.Supplement_2.42S.119","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1385-5"},{"key":"2021051712024087000_52.Supplement_2.42S.120","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.4569"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.110.085753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T19:39:10Z","timestamp":1621280350000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.110.085753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":120,"journal-issue":{"issue":"Supplement 2","published-online":{"date-parts":[[2011,12,5]]},"published-print":{"date-parts":[[2011,12]]}},"alternative-id":["10.2967\/jnumed.110.085753"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.110.085753","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}